了解和克服在生殖尿路癌症中对免疫治疗的耐药性
Sean T Evans1, Yash Jani2, Caroline S Jansen3,4
1Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Cancer biology & therapy
|April 17, 2024
概括
免疫检查点抑制剂 (ICI) 改变了生殖尿道癌症的治疗方法,但耐药性很常见. 研究探讨了耐药性和组合疗法的机制,包括向药物,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生殖尿道癌症 生殖尿道癌症
背景情况:
- 新型免疫疗法,特别是免疫检查点抑制剂 (ICI),现在是对某些生殖尿道 (GU) 癌症的标准治疗.
- 尽管有效,但对ICI的内在或获得性耐药性限制了它们在许多患者中的有效性.
- 了解耐药机制对于改善GU恶性瘤治疗策略至关重要.
研究的目的:
- 提供GU癌症免疫疗法耐药性机制的全面概述.
- 审查预测免疫治疗反应或耐药性的生物标志物.
- 探索克服免疫疗法耐药性的现有和新兴策略.
主要方法:
- 关于生殖尿路癌症免疫疗法耐药性研究的文献综述.
- 对识别与ICI反应相关的遗传标记物,细胞因子和蛋白质的研究进行分析.
- 对组合疗法 (ICI + 化疗,向疗法,疫苗,辐射) 和新型向药物的评估.
主要成果:
- 一些遗传标记物,细胞因子和蛋白质已被确定为免疫治疗反应或耐药性的潜在预测因素.
- 组合疗法,包括顺序治疗和新型向药物,在克服耐药性方面表现有前途.
- 向治疗和对免疫调解物的更深入理解是正在进行的研究的关键领域.
结论:
- 免疫疗法耐药性是GU癌症治疗中的一个重大挑战.
- 组合策略和新型向疗法是提高治疗疗效的有希望的途径.
- 需要进一步的研究来确定可靠的反应预测因子,并优化治疗选择.
关键词:
尼沃卢马布的使用情况免疫检查点抑制剂 免疫检查点抑制剂免疫疗法 免疫疗法免疫疗法耐药性 免疫疗法耐药性这里是 ipilimumab 的所在地.编程细胞死亡蛋白-1 (PD-1) 编程细胞死亡蛋白-1编程死亡连接体-1 (PD-L1) 编程死亡连接体-1 (PD-L1)前列腺癌是前列腺癌.细胞癌瘤是细胞癌.尿路细胞癌的癌症.更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K